1. 1. Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC (2017) Pathogenesis of human systemic lupus erythematosus: A cellular perspective. Trends in Molecular Medicine, 23(7): 615-35. [DOI:10.1016/j.molmed.2017.05.006]

2. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1): 7-30. [DOI:10.3322/caac.21590]

3. Chen Y, Tao T, Wang W, Yang B, Cha X (2021) Dihydroartemisinin attenuated the symptoms of a mouse model of systemic lupus erythematosus by restoring the Treg/Th17 balance. Clinical and Experimental Pharmacology and Physiology, 48(4): 626-33. [DOI:10.1111/1440-1681.13461]

4. Woo JMP, Parks CG, Jacobsen S, Costenbader KH, Bernatsky S (2022) The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematosus. Journal of Internal Medicine, 291(6): 653-74. [DOI:10.1111/joim.13448]

5. Bernatsky S, Boivin JF, Joseph L, et al. (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis & Rheumatism, 52(5): 1481-90. [DOI:10.1002/art.21029]

6. Ju JH, Min JK, Jung CK, et al. (2009)Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nature Reviews Rheumatology, 5(5): 273-81. [DOI:10.1038/nrrheum.2009.53]

7. Muñoz-Urbano M, Sangle S, D'Cruz DP (2024) Lupus enteritis: A narrative review. Rheumatology (Oxford), 63(6): 1494-501. [DOI:10.1093/rheumatology/kead689]

8. Kasturi S and Sammaritano LR (2016) Corticosteroids in lupus. Rheumatic Disease Clinics of North America, 42(1): 47-62. [DOI:10.1016/j.rdc.2015.08.007]

9. Qi F, Li A, Inagaki Y, et al. (2010) Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Bioscience Trends, 4(6): 297-307.

10. Zhang Q, Li Y, Liu D, et al. (2021) Integrative approaches combining Traditional Chinese Medicine and radiotherapy in cancer treatment. Chinese Medicine, 16: 45. [DOI:10.1186/s13020-021-00455-w]

11. Heo SB, Lim SW, Jhun JY, Cho ML, Chung BH, Yang CW (2016) Immunological benefits of ginseng through reciprocal regulation of Th17 and Treg cells during cyclosporine-induced immunosuppression. Journal of Ginseng Research, 40(1): 18-27. [DOI:10.1016/j.jgr.2015.04.005]

12. Yi YS (2019) Ameliorative effects of ginseng and ginsenosides on rheumatic diseases. Journal of Ginseng Research, 43(3): 335-41. [DOI:10.1016/j.jgr.2018.04.004]

13. Chen Z, Liu L, Gao C, et al. (2020) Astragali Radix (Huangqi): A promising edible immunomodulatory herbal medicine. Journal of Ethnopharmacology, 258:112895. [DOI:10.1016/j.jep.2020.112895]

14. Wang H, Jin J, Zhang Q, et al. (2020) Astragalus polysaccharide mitigates radiotherapy-induced immune suppression in cancer patients. Int J Radiat Oncol Biol Phys, 108(3): S125-S6.

15. Xu J, Liu Y, Guo X, et al. (2021) Tripterygium wilfordii Hook F: Immunosuppressive effects in cancer patients undergoing radiotherapy. Frontiers in Pharmacology, 12: 686071.

16. Chen L, He Q, Luo M, et al. (2021) Clinical features of lupus enteritis: A single-center retrospective study. Orphanet J Rare Diseases, 16(1): 204. [DOI:10.1186/s13023-021-02044-4]

17. Zeng L, Yang T, Yang K, et al. (2022) Curcumin and Curcuma longa extract in the treatment of autoimmune diseases: Systematic review and meta-analysis of 31 RCTs. Frontiers in Immunology, 13: 896476. [DOI:10.3389/fimmu.2022.896476]

18. Cai Z, Wong CK, Dong J, et al. (2016) Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus. Chinese Medicine, 11: 23. [DOI:10.1186/s13020-016-0093-x]

19. Zhang Y, Zhang X, Wang Y, et al. (2019) Ganoderma lucidum polysaccharides reduce radiotherapy-induced toxicities in cancer treatment. Integrative Cancer Therapies, 18: 1534735419871192.

20. Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA (2015) Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine, 72(2): 146-53. [DOI:10.1016/j.cyto.2014.12.027]

21. Ma X, Zhong J, Liu Y, et al. (2019) Ginsenosides from Panax ginseng as potential therapeutic candidates for cancer patients with autoimmune diseases. Phytomedicine, 58: 152874.

22. Du Y, Wan H, Huang P, Yang J, He Y (2022) A critical review of Astragalus polysaccharides: From therapeutic mechanisms to pharmaceutics. Biomedicine & Pharmacotherapy, 147: 112654. [DOI:10.1016/j.biopha.2022.112654]

23. Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y (2020) A review of the pharmacological action of astragalus polysaccharide. Frontiers in Pharmacology, 11: 2020. [DOI:10.3389/fphar.2020.00349]

24. Li C-x, Liu Y, Zhang Y-z, Li J-c, Lai J (2022) Astragalus polysaccharide: a review of its immunomodulatory effect. Archives of Pharmacal Research, 45(6): 367-89.

25. Luo D, Zuo Z, Zhao H, et al. (2019) Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice. Frontiers in Medicine,13(5): 556-63. [DOI:10.1007/s11684-018-0649-5]

26. Xi C, Peng S, Wu Z, Zhou Q, Zhou J (2017) Toxicity of triptolide and the molecular mechanisms involved. Biomedicine & Pharmacotherapy, 90: 531-41. [DOI:10.1016/j.biopha.2017.04.003]

27. Ramessar N, Borad A, Schlesinger N (2023) The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review. Lupus, 32(5): 644-57. [DOI:10.1177/09612033231161961]

28. Efferth T and Oesch F (2021) The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases. Medicinal Research Reviews, 41(6): 3023-61. [DOI:10.1002/med.21842]

29. Lin ZB (2005) Cellular and molecular mechanisms of immunomodulation by Ganoderma lucidum. J Pharmacological Sciences, 99(2): 144-53. [DOI:10.1254/jphs.CRJ05008X]

30. Wei H and Yongming Z (2009) Function of Traditional Chinese Medicine in Cancer Radiotherapy and its Prospect. World Science and Technology, 11(5): 742-6. [DOI:10.1016/S1876-3553(10)60035-X]

31. Qin R, Jiang Y, Shen L, Qian J, Kang Y, Fan R, et al. (2025) Impact of Traditional Chinese Medicine therapy focused on strengthening the body on postoperative recurrence and metastasis prevention in stage IIIA non-small cell lung cancer: a real-world retrospective cohort study. Chinese Medicine, 20(1): 137. [DOI:10.1186/s13020-025-01195-x]

32. Wu T, Yang L, Chen Y, et al. (2021) Traditional Chinese Medicine reduces gastrointestinal complications in cancer patients undergoing radiotherapy. J Cancer Research and Clinical Oncology, 147(9): 2567-76.

33. Li J, Wu M, Liu W (2025) Astragalus-containing Chinese herbal medicine used with Western medicine for lupus nephritis: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology, 15: 2024. [DOI:10.3389/fphar.2024.1395844]

34. Cheng Y-C, Wang Y-M, Lin Y-H, Cheng J-Y, Li S-H, Huang Y-C, et al. (2022) Preventive effect and safety of Chinese herbal medicine for oral mucositis during radiotherapy in patients with head and neck cancer: Study protocol for a randomized trial. Contemporary Clinical Trials Communications, 27: 100912. [DOI:10.1016/j.conctc.2022.100912]

35. Wu T, Fu C, Deng Y, Huang W, Wang J, Jiao Y (2022) Acupuncture therapy for radiotherapy-induced adverse effect: A systematic review and network meta-analysis. Frontiers in Public Health, 10: 2022. [DOI:10.3389/fpubh.2022.1026971]

36. Lo L, Chen C, Chang C, Lee T, Hou M, Cheng T, et al. (2012) P02.34. Therapeutic effects of traditional Chinese medicine in cancer patients undergoing chemotherapy or radiotherapy: randomized, double-blind controlled trial. BMC Complementary and Alternative Medicine, 12(1): P90. [DOI:10.1186/1472-6882-12-S1-P90]

37. Wu D, Zhang Y, Zou B, Lu Y, Cao H (2023) Shaoyao decoction alleviates TNBS-induced ulcerative colitis by decreasing inflammation and balancing the homeostasis of Th17/Treg cells. BMC Complementary Medicine and Therapies, 23(1): 424. [DOI:10.1186/s12906-023-04237-9]

38. Zhang X, Chen X, Wang L, He C, Shi Z, Fu Q, et al. (2021) Review of the efficacy and mechanisms of traditional Chinese medicines as a therapeutic option for ionizing radiation induced damage. Frontiers in Pharmacology, 12: 2021. [DOI:10.3389/fphar.2021.617559]

39. Liu L, Zhang L, Li M (2022) Application of herbal traditional Chinese medicine in the treatment of lupus nephritis. Frontiers in Pharmacology, 13: 2022. [DOI:10.3389/fphar.2022.981063]

40. Cao C, Wang Z, Gong G, Huang W, Huang L, Song S, et al. (2022) Effects of Lycium barbarum Polysaccharides on Immunity and Metabolic Syndrome Associated with the Modulation of Gut Microbiota: A review. Foods, 11(20): 3177. [DOI:10.3390/foods11203177]

41. Zhou Y, Zhang D, Cheng H, Wu J, Liu J, Feng W, et al. (2024) Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota. Frontiers in Cellular and Infection Microbiology, 14: 2024. [DOI:10.3389/fcimb.2024.1389925]

42. Li Y, Zhang Y, Wei K, He J, Ding N, Hua J, et al. (2021) Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury. Frontiers in Cellular and Infection Microbiology, 11: 2021. [DOI:10.3389/fcimb.2021.577236]

43. He L, Edi S, Ma J, Kong Z, Dai C, Huang L, et al. (2025) Prevention and treatment of radiation injury by traditional Chinese medicine: A review. Chinese Herbal Medicines,17(2): 220-34. [DOI:10.1016/j.chmed.2024.09.005]